Differentially expressed microRNAs at different stages of atherosclerosis in ApoE-deficient mice

Chinese Medical Journal

Volumn 126, Issue 3, 2013, Pages 515-520

  Shan, Zhen ^a   Yao, Chen ^a   Li, Zi Lun ^a   Teng, Yuan ^a   Li, Wen ^a   Wang, Jin Song ^a   Ye, Cai Sheng ^a   Chang, Guang Qi ^a   Huang, Xue Ling ^a   Li, Xiao Xi ^a   Wang, Wen Jian ^a   Wang, Shen Ming ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Animal model; Atherosclerosis; Microarray analysis; MicroRNAs

Indexed keywords

MICRORNA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DISEASE COURSE; DOWN REGULATION; FOAM CELL; HYBRIDIZATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; UPREGULATION;

ANIMALS; APOLIPOPROTEINS E; ATHEROSCLEROSIS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84873482502     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20122289     Document Type: Article

References (29)

1. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: 480-486.
2. Li JJ. Inflammation in coronary artery diseases. Chin Med J 2011; 124: 3568-3575.
3. Piedrahita JA, Zhang SH, Hagaman JR, Oliver PM, Maeda N. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc Natl Acad Sci U S A 1992; 89: 4471-4475.
4. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994; 14: 133-140.
5. Napoli C, Palinski W, Di Minno G, D'Armiento FP. Determination of atherogenesis in apolipoprotein E-knockoutmice. Nutr Metab Cardiovasc Dis 2000; 10: 209-215.
6. Reddick RL, Zhang SH, Maeda N. Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. Arterioscler Thromb 1994; 14: 141-147.
7. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355.
8. Seo D, Wang T, Dressman H, Herderick EE, Iversen ES, Dong C, et al. Gene expression phenotypes of atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24: 1922-1927.
9. Tabibiazar R, Wagner RA, Ashley EA, King JY, Ferrara R, Spin JM, et al. Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease. Physiol Genomics 2005; 22: 213-226.
10. Breslow JL. Mouse models of atherosclerosis. Science 1996; 272: 685-688.
11. Wuttge DM, Sirsjo A, Eriksson P, Stemme S. Gene expression in atherosclerotic lesion of ApoE deficient mice. Mol Med 2001; 7: 383-392.
12. Stary HC, Chandler AB, Glagov S, Guyton JR, Insull WJ, Rosenfeld ME, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994; 89: 2462-2478.
13. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
14. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006; 20: 515-524.
15. Eulalio A, Huntzinger E, Izaurralde E. Getting to the root of miRNA-mediated gene silencing. Cell 2008; 132: 9-14.
16. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005; 120: 15-20.
17. Zhang C. MicroRNomics: a newly emerging approach for disease biology. Physiol Genomics 2008; 33: 139-147.
18. Qin S, Zhang C. MicroRNAs in vascular disease. J Cardiovasc Pharmacol 2011; 57: 8-12.
19. Song Z, Li G. Role of specific microRNAs in regulation of vascular smooth muscle cell differentiation and the response to injury. J Cardiovasc Transl Res 2010; 3: 246-250.
20. Ji R, Cheng Y, Yue J, Yang J, Liu X, Chen H, et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of microRNA in vascular neointimal lesion formation. Circ Res 2007; 100: 1579-1588.
21. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009; 460: 705-710.
22. Zhang C. MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease. Cell Cycle 2009; 8: 3469-3473.
23. Elia L, Quintavalle M, Zhang J, Contu R, Cossu L, Latronico MV, et al. The knockout of miR-143 and-145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease. Cell Death Differ 2009; 16: 1590-1598.
24. Liu X, Cheng Y, Zhang S, Lin Y, Yang J, Zhang C. A necessary role of miR-221 and miR-222 in vascular smooth muscle cell proliferation and neointimal hyperplasia. Circ Res 2009; 104: 476-487.
25. Raitoharju E, Lyytikainen LP, Levula M, Oksala N, Mennander A, Tarkka M, et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study. Atherosclerosis 2011; 219: 211-217.
26. Busch M, Zernecke A. microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis. J Mol Med 2012; 90: 877-885.
27. Rotllan N, Fernandez-Hernando C. MicroRNA regulation of cholesterol metabolism. Cholesterol 2012; 2012: 847-849.
28. Qin B, Xiao B, Liang D, Xia J, Li Y, Yang H. MicroRNAs expression in ox-LDL treated HUVECs: MiR-365 modulates apoptosis and Bcl-2 expression. Biochem Biophys Res Commun 2011; 410: 127-133.
29. Ito T, Yagi S, Yamakuchi M. MicroRNA-34a regulation of endothelial senescence. Biochem Biophys Res Commun 2010; 398: 735-740.